A heparin-like compound isolated from a marine crab rich in glucuronic acid 2-O-sulfate presents low anticoagulant activity  by Andrade, Giulianna P.V. et al.
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a  b  s  t  r  a  c  t
A  natural  heparin-like  compound  isolated  from  the  crab  Goniopsis  cruentata  was structurally  character-
ized  and  its anticoagulant  and  hemorrhagic  activities  were  determined.  Enzymatic  and  nuclear  magnetic
resonance  analysis  revealed  that  its structure  is  rich  in  disulfated  disaccharides,  possessing  signiﬁcant
amounts  of  2-O-sulfated--d-glucuronic  acid units.  Furthermore,  low  amounts  of  trisulfated  disaccharide
units  containing  2-O-sulfated--l-iduronic  acid  were  detected,  when  compared  to mammalian  heparin.
In  addition,  this  heparin-like  structure  showed  negligible  in  vitro  anticoagulant  activity  and  low  bleeding
potency,  facts  that make  it a suitable  candidate  for the  development  of structure-driven,  heparin  basedeywords:
eparin
eparan sulfate
uclear  magnetic resonance
eparinases
therapeutic  agents  with  fewer  undesirable  effects.
© 2013 Elsevier Ltd. Open access under the Elsevier OA license.nticoagulant  activity
emorrhagic  effect
. Introduction
Heparin and low molecular weight heparins are the main anti-
oagulant and antithrombotic drugs currently used in medicine.
esides its well-described anticoagulant/antithrombotic actions,
eparin and heparin-like molecules are known to interact with
ultiple proteins modulating several biological processes (Brito
t al., 2008; Dreyfuss et al., 2010; Paredes-Gamero et al., 2010),
owever, its further clinical use is impaired by its strong anticoag-
lant activity and hemorrhagic complications.
Heparin and heparan sulfate share structural features, yet, they
an be differentiated by the levels of glucosamine N-acetylation,
otal sulfate and glucuronic/iduronic acid ratio (Casu, Naggi, & Torri,
010). Furthermore, heparan sulfates are ubiquitous components
f all tissue-organized animal life forms (Cassaro & Dietrich, 1977;
edeiros et al., 2000; Sampaio et al., 2006; Toledo & Dietrich, 1977),
∗ Corresponding author at: Molecular Biology, Departamento de Bioquímica, Uni-
ersidade Federal de São Paulo, Rua Três de Maio, 100, CEP 04044-020, São Paulo,
P,  Brazil. Tel.: +55 11 5570 3175; fax: +55 11 5573 6407.
E-mail address: hbnader.bioq@epm.br (H.B. Nader).
144-8617     ©  2013 Elsevier Ltd. 
ttp://dx.doi.org/10.1016/j.carbpol.2013.01.069
Open access under the Elsevier OA license.whereas heparin shows a peculiar distribution in mammalian and
other vertebrates, as well as in invertebrates (Nader, Lopes, Rocha,
Santos, & Dietrich, 2004).
In invertebrates, heparin is found in some species of mollusk,
crustacean, annelid, echinodermate, tunicate and urochordate life
(Cassaro & Dietrich, 1977; Cavalcante et al., 2000; Dietrich et al.,
1985; Luppi, Cesaretti, & Volpi, 2005; Medeiros et al., 2000; Pejler
et al., 1987; Sampaio et al., 2006). In some invertebrates, the pres-
ence of heparin-like structures with similarities to heparin but,
with some structural peculiarities, have been described (Brito et al.,
2008; Chavante et al., 2000; Dietrich et al., 1999a; Nader et al.,
2004). These previous studies have shown that their structures
vary according to the species and that such differences reside,
mainly, in the relative abundance of the different disaccharide units
(Nader et al., 2004). Additionally, these heparin-like compounds
show variable biological activities (Boucas et al., 2006; Brito et al.,
2008; Cassaro & Dietrich, 1977; Chavante et al., 2000; Dietrich
et al., 1999a; Dreyfuss et al., 2010; Medeiros et al., 2000; Santos
et al., 2007). Thus, each heparin/heparin-like compound from
invertebrate tissues tends to be a hitherto unknown compound
with unique structural features and a potential novel therapeutic
agent.
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In the present manuscript, the isolation, structural charac-
erization and anticoagulant activity of an unusual heparin-like
ompound present in tissues of the crab Goniopsis cruentata are
escribed.
. Materials and methods
.1.  Materials
Heparan sulfate from bovine pancreas and heparin from bovine
ntestinal mucosa were gifts from the late Dr. P. Bianchini (Opocrin
esearch Laboratories, Corlo, Modena, Italy). Heparin from porcine
ntestinal mucosa was obtained from Kin Master (Passo Fundo,
S, Brazil) and enoxaparin (low molecular weight heparin) from
anoﬁ-Aventis (Maison-Alford, France). Chondroitin 4- and 6-
ulfate and dermatan sulfate were purchased from Seikagaku
ogyo (Tokyo, Japan). Heparinase (Heparinase I, EC 4.2.2.7), hep-
ritinases I and II were prepared from Flavobacterium heparinum
s previously described (Nader et al., 1990). Ethylenediamine
1,2-diaminoethane) and propylenediamine (1,3-diaminopropane)
ere purchased from Sigma–Aldrich Co. (Milwaukee, WI,  USA).
ow-Mr agarose was purchased from Bio-Rad (Richmond, CA,
SA). Maxatase, a protease from Sporobacillus, was purchased
rom Biocon do Brasil Industrial Ltd. (Rio de Janeiro, RJ,
razil).
.2. Extraction and puriﬁcation of crab heparin-like
The Animal Ethics Advisory Committee approved all experi-
ents involving animals in accordance to the Brazilian Federal
aw (11,794/2008) for the use and care of animals for scientiﬁc
urposes. Adult specimens of G. cruentata (Latreill, 1803) were
ollected at Potengi river estuary (Macaíba, RN, Brazil), immedi-
tely killed and stored at −20 ◦C. Sulfated glycosaminoglycans were
xtracted after proteolysis and ion exchange fractionation. Ten kilo-
rams of crab were ground with 2 volumes of cold 0.5 M NaCl in
 blender. The pH of the mixture was adjusted to 8.0 with NaOH
nd Maxatase was added (3.5 mg/kg wet weight). After incubat-
ng for 24 h at 60 ◦C, with agitation and periodic pH adjustments,
he mixture was ﬁltered and Lewatit ion exchange resin (Bayer,
P, Brazil) was added (60 mg/kg wet weight), and the resulting
ixture was agitated for 24 h at 60 ◦C under a layer of toluene.
he suspension was again ﬁltered and the resin retained, washed
ith 10 volumes of water at 60 ◦C and, subsequently, washed
ith 10 volumes of 0.5 M NaCl at room temperature. The washed
esin was then suspended in 2 volumes of 1 M NaCl, agitated for
 h and ﬁltered again. This procedure was repeated using with
 and 3 M NaCl. The ﬁltrates were maintained for 24 h at 4 ◦C
fter the addition of 2 volumes of methanol and the precipi-
ate formed was collected by centrifugation (10,000 × g, 20 min),
ried under vacuum, suspended in distilled water, and analyzed
y agarose gel electrophoresis. Fractions eluted with 2 and 3 M
aCl, which showed the presence of compounds migrating as hep-
rin and heparan sulfate were pooled, dialyzed and dried. These
ompounds were further dissolved in 0.15 M NaCl and 0.5 vol-
mes of ice-cold acetone was added to the solution under gentle
gitation and maintained at 4 ◦C for 24 h. The precipitate was
ollected by centrifugation at 4 ◦C. This procedure was  repeated
uccessively by addition to the supernatant of 0.6, 0.7, 0.8, 0.9, 1.0
nd 2.0 volumes of acetone according to the volume of the ini-
ial solution. The resulting precipitates were dialyzed, dried and
nalyzed. Fractions precipitated with 0.6 volumes and 0.7 vol-
mes of acetone corresponded to 90% of the total heparin-like
ompound. Polymers 94 (2013) 647– 654
2.3. Agarose gel electrophoresis
Agarose  gel electrophoresis were performed in 0.6% agarose
gels (7.5 cm × 10 cm,  0.2 cm thick) prepared in three differ-
ent buffers: 0.05 M 1,3-diaminopropane–acetate buffer, pH 9.0,
discontinuous buffer 0.04 M barium acetate, pH 4.0/0.05 M
diaminopropane–acetate, pH 9.0 or 0.06 M Tris–acetate buffer, pH
8.0, as previously described (Bianchini et al., 1980). Aliquots of the
fractions (about 10 g) were applied to the gel and subjected to
electrophoresis. The gels were ﬁxed with 0.1% cetyltrimethylam-
monium bromide (CETAVLON) solution for 4 h, dried and stained for
15 min  with 0.1% toluidine blue in 1% acetic acid in 50% ethanol and
further destained with the same solution without the dye. Quantiﬁ-
cation was  carried out by densitometry at 530 nm of the toluidine
blue-stained electrophoretic slide. The extinction coefﬁcients of the
GAGs were calculated using standards of chondroitin sulfate (CS),
dermatan sulfate (DS) and heparan sulfate (HS). The error of the
method was in the order of 5%. Identiﬁcation of the sulfated GAGs
was initially based on the migration of the compounds compared
with those of standards.
2.4.  Enzymatic degradation
Samples  were incubated with different heparin lyases (hepari-
nase I, heparitinase I and II, 2.5 mIU  each) as well as with a mixture
of all enzymes. The disaccharides produced by the enzymatic action
were resolved on a 150 × 4.6 mm Phenosphere SAX column (Phen-
omenex, Torrance, CA, USA) using a NaCl gradient of 0–1 M during
30 min with a 1 mL/min ﬂux and UV detection at 232 nm.
2.5.  NMR  spectroscopy
NMR  spectra were recorded either using a Bruker DRX 600 with a
triple resonance 5-mm probe or in an Agilent 600 MHz  System with
5-mm Cold Probe. The spectra were recorded at either 60 or 25 ◦C
with HOD suppression by pre-saturation. COSY, TOCSY and 1H/13C
heteronuclear correlation (HSQC) spectra were recorded using
states-time proportion phase increment for quadrature detection
in the indirect dimension. All chemical shifts were relative to exter-
nal trimethylsilyl-propionic acid and [13C]-methanol.
2.6. In vitro anticoagulant activity
All coagulation assays (aPTT, PT, TT and HEPTEST®) were per-
formed using a coagulometer as described earlier (Dietrich et al.,
1999a) using citrated normal human plasma. All assays were per-
formed in duplicate and repeated at least three times on different
days (n = 6). Generation of thrombin and factor Xa was  measured
by amidolytic assays using the speciﬁc chromogenic substrates
(Spectrozyme TH and Spectrozyme FXa, American Diagnostica Inc.,
Stamford, CT) according to a method previously described (Kaiser
et al., 1992). All assays were performed on a fast kinetic centrifugal
analyzer (ACL-300, Lexington, MA,  USA).
2.7. Hemorrhagic effect
Hemorrhagic  activity of the heparin-like compound was  mea-
sured in a rat-tail model as previously described (Dietrich et al.,
1999b). Following anesthesia with nembutal (40 mg/kg) and uret-
hane (0.8 g/kg), scariﬁcation with a razor blade (1–2 mm deep,
5 mm long) was  made 15 mm from the distal part of the rat tail
(males, three months old). The tail was  then immersed in isotonic
NaCl, scraped with gauze, and immersed again in fresh saline to
observe bleeding. Normal bleeding ranged from 30 to 60 s. Grazed
tails were then immersed in saline solution containing the crab
heparin-like compound or mammalian heparin (200 g/mL) for
G.P.V. Andrade et al. / Carbohydrate Polymers 94 (2013) 647– 654 649
Fig. 1. Electrophoretic behavior of the crab sulfated glycosaminoglycans in agarose gels. About 5–20 g of the glycosaminoglycans puriﬁed from crab tissues were subjected
to  electrophoresis in different buffers. After the run, the compounds were precipitated and the gels dried and stained with toluidine blue. (a) Fractions eluted from the ion
exchange chromatography were evaluated using 1,3-diaminopropane-acetate (PDA). 1 M,  2 M and 3 M fractions were eluted from ion exchange chromatography with 1.0,
2.0  and 3.0 M of NaCl, respectively. (b) Fractions 2 M and 3 M were pooled and fractionated with acetone, and the electrophoretic mobility of the compounds evaluated using
the  discontinuous buffer barium acetate/PDA. Electrophoretic mobility of the heparin-like compounds precipitated with 0.6 and 0.7 volumes of acetone in different buffers:
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CS),  dermatan sulfate (DS) and heparan sulfate (HS); Hep, porcine intestinal muco
rigin.
 min  and washed extensively with saline. The treated tails were
hen immersed in isotonic saline solution, and the amount of
lood oozed was measured by protein content. The bleeding was
bserved with the use of a stereoscope. All experiments were per-
ormed at 37 ◦C. The bleeding was calculated as the sum of the
rotein values of each tube minus the amount of protein present
efore the exposure to the test substances. Bleeding potency was
xpressed as the cumulative amount of protein released from the
ounds after exposure to the compounds relative to the control
absence of drug).
.8.  Other methods
Hexosamine was determined after acid hydrolysis (4 M HCl,
00 ◦C, 6 h) by the Rondle–Morgan procedure (Rondle & Morgan,
955) and uronic acid by the carbazole reaction (Dische, 1947).
otal sulfate was measured by a method previously described
Dodgson & Price, 1962). For molecular weight analysis, 300 g
f each sample was analyzed by GPC-HPLC on a 300 mm × 7.8 mm
ioSep SECTM S-2000 LC Column. The samples were submitted to
n isocratic elution (0.3 M Na2SO4 mobile phase) at a ﬂow rate
f 1 mL/min and UV detection at 205 nm.  The column was  previ-
usly calibrated with polysaccharides of known molecular weights
1.7 kDa, 4 kDa, 10 kDa, 16 kDa and 20 kDa).
.9. Statistical analysisThe  SPSS software package (release 16.0; SPSS Inc., Chicago,
L, USA) was used for statistical analysis. The difference between
he groups was evaluated using the non-parametric two-tailedre of standard sulfated glycosaminoglycans containing 5 g of chondroitin sulfate
arin and S, I, F, slow, intermediate and fast moving components, respectively; Or,
Mann–Whitney U-test. P < 0.05 was  considered statistically signif-
icant.
3. Results and discussion
3.1.  Puriﬁcation of the crab heparin-like compound
A natural heparin-like compound was obtained from the crab
G. cruentata after proteolysis, ion-exchange chromatography and
acetone fractionation. The fractions eluted with 2 M and 3 M NaCl
were rich in compounds with electrophoretic characteristics of
heparin/heparan sulfate (Fig. 1a). Consequently, these fractions
were pooled and fractionated by stepwise addition of different vol-
umes of acetone (Fig. 1b). The fractions precipitated with 0.6 and
0.7 volumes of acetone showed similar electrophoretic mobility in
the diamino-propane-acetate (PDA) buffer. Hence, the purity and
similarity of these fractions were further conﬁrmed by agarose gel
electrophoresis using three different buffers. In PDA buffer, these
fractions presented a single band with electrophoretic mobility
between heparan sulfate and dermatan sulfate (Fig. 1c). In contrast,
in Tris–acetate buffer they showed electrophoretic mobility simi-
lar to heparin (Fig. 1d). Furthermore, in the discontinuous system
barium/PDA, while heparin was  fractionated into 3 different com-
ponents (Bianchini et al., 1980), the crab heparin-like compounds
showed one main component with higher migration than the hep-
arin fast moving band (Fig. 1e). Such electrophoretic behavior in
different buffers is the preliminary indication that the structural
characteristics of the crab heparin-like compound (sulfation pat-
tern and/or glucuronic and iduronic acid) are different to heparin
and other sulfated GAGs. Chavante et al. (2000) isolated, from the
650 G.P.V.  Andrade et al. / Carbohydrate Polymers 94 (2013) 647– 654
Table 1
Relative Hepn disaccharide composition.
Percentage (%)
UA-NAc UA-NS UA-NAc(6S) UA(2S)-NAc UA-NS(6S) UA(2S)-NS UA(2S)-NAc(6S) UA(2S)-NS(6S)
≤1 45.9 8.1 7.5 5.1 18.0 3.0 12.0
F in rec
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gig. 2. 1H spectra at 600 MHz  of the crab heparin-like, heparan sulfate and hepar
pectrum; (b) 1H spectra anomeric region of crab Hepn, heparan sulfate from bov
NAc, N-acetylated glucosamine; G, glucuronic acid; G2S, 2-O-sulfated glucuronic ac
rustacean Artemia franciscana, an unusual heparan sulfate with
imilar electrophoretic behavior to the crab compound that pre-
ented a high degree of N-sulfation. On the other hand, a compound
rom the shrimp Penaeus brasiliensis with similar electrophoretic
ehavior was isolated and characterized as a natural low molecular
eight heparin (Dietrich et al., 1999a).
.2. Chemical analysis and molecular mass
The molecular mass and the molar ratios of hexosamine, uronic
cid and sulfate present in the heparin-like compounds, mam-
alian heparin and heparan sulfate were also analyzed. The crab
ompounds showed an average molecular mass (∼19 kDa) similar
o porcine heparin (∼16 kDa) and lower when compared to bovine
eparan sulfate (∼25 kDa). Furthermore, both compounds showed
ig. 3. 1H/13C HSQC (b) and 1H/1H COSY (b) spectra of the crab heparin-like compound r
lucuronic acid; G2S, 2-O-sulfated glucuronic acid; I2S, 2-O sulfated iduronic acid.orded at 60 ◦C and 25 ◦C respectively. (a) Crab heparin-like compound (Hepn) 1H
ncreas and heparin from porcine intestinal mucosa. ANS, N-sulfated glucosamine;
, 2-O sulfated iduronic acid; I, iduronic acid; G, glucuronic acid.
similar  molar ratio of sulfate/hexosamine of 2.1:1.0, respectively.
These ratios are between the values described for heparan sulfate
(sulfate/hexosamine, 1.6:1.0) (Dietrich & Nader, 1974) and heparin
(sulfate/hexosamine, 2.8:1.0) (Dietrich et al., 1985). Neutral sugars
were not detected. Overall, the data suggested that the two frac-
tions corresponded to the same compound. The two  fractions were
pooled and hereafter is referred to as Hepn.
3.3. Enzymatic analysis
Some  structural characteristics of the Hepn were exam-
ined with enzymes puriﬁed from F. heparinum. Heparitinase I,
which acts upon N-acetyl or N-sulfate glucosamine-glucuronic
acid  linkages (Desai, Wang, & Linhardt, 1993; Dietrich et al.,
1999a; Silva & Dietrich, 1974), degraded less than 5% of the
ecorded at 60 ◦C. ANS, N-sulfated glucosamine; ANAc, N-acetylated glucosamine; G,
G.P.V. Andrade et al. / Carbohydrate Polymers 94 (2013) 647– 654 651
Table 2
1H chemical shifts for the heparin-like compound of the crab G. cruentata.
Unit 1H chemical shiftsa
Uronic acid Glucosamine
H1 H2 H3 H4 H5 H1 H2 H3  H4 H5 H6
a(-GlcA)→(-d-GlcNS-6S) (I)→(A) 4.60 3.31 3.71 3.88 3.79 5.57 3.18 3.65 3.85 4.04 4.14
b-GlcA→-d-GlcNS-6S 4.58 3.36 3.82 3.84 3.78 5.56 3.27 3.67 3.70 3.96 4.37/4.17
a(-GlcA)→(-d-GlcNS) (I′)→(A′) 4.58 3.28 3.70 3.88 3.79 5.57 3.18 3.65 3.65 3.75 3.80
b-GlcA→-d-GlcNS 4.55 3.41 3.83 3.90 3.83 5.58 3.27 3.68 3.68 3.79 3.81/3.83
a(-GlcA-2S)→(-d-GlcNS) (H)→(B) 4.67 4.12 ∼4.03 ∼3.97 – 5.55 3.24 3.62 3.86 3.72 3.92
c-GlcA-2S→-d-GlcNS 4.69 4.12 3.99 3.83 – 5.45 3.23 3.75 3.64 3.93 3.88
a(-GlcA-2S)→(-d-GlcNS-6S)(H′)→(B′) 4.70 4.12 ∼4.03 ∼3.97 – 5.55 3.24 3.62 3.86 4.04 4.14
b-GlcA-2S→-d-GlcNS-6S 4.74 4.14 3.98 3.85 3.88 5.44 – – – – –
a(-IdoA-2S)→(-d-GlcNS-6S) (F)→(C) 5.20 4.28 4.22 4.08 5.01 5.48 3.19 – – – ∼4.40
d-IdoA-2S→-d-GlcNS-6S 5.23 4.37 4.22 4.14 4.82 5.42 3.31 3.69 3.79 4.05 4.42/4.30
a(-GlcA-2S)→(-d-GlcNAc-6S)(G)→(D) 4.73 4.08 – – – 5.32 3.83 3.92 3.77 4.15 4.25
e-GlcA-2S→-d-GlcNAc-6S 4.76 4.14 3.92 – – 5.42/5.32 4.03/3.93 3.85 3.57 4.04 4.48/4.22
e(-GlcA)→(-d-GlcNAc-6S) 4.52  3.34 3.65 3.78 3.82 5.32 3.80 – – 4.15 4.47
(G′)→(D′) f-GlcA→-d-GlcNAc 4.64 3.41 3.66 3.75 – 5.35 3.91 3.75 3.70 3.99 –
a(-GlcA)→(-d-GlcNAc) (J)→(E) 4.49 3.34 3.65 3.78 3.82 5.28 3.85 3.98 3.48 3.90 3.89
b-GlcA→-d-GlcNAc 4.48 3.37 3.69 3.78 3.78 5.36 3.89 3.86 3.64 3.82 3.84/3.84
Values in italic type indicate positions bearing a sulfate ester. A to F, spin systems.
a Data presented in this paper.
b Casu et al. (1994).
c Yamada et al. (1995).
c
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Vd Yates et al. (1996).
e Guerrini et al. (2005).
f Yamada et al. (1999).
rab heparin-like product, producing few N-acetylated and N-
ulfated disaccharides linked to non-sulfated glucuronic acid
UGlcA-GlcNS and UGlcA-GlcNAc). On the other hand, hep-
rinase degraded the crab compound producing the same types
f products obtained from the mammalian heparin, although
n different proportions. This enzyme acts upon glycosidic
inkages containing -d-glucosamine-N-sulfate linked to -l-
duronic acid-2-sulfate and does not act when the uronic acid is
able 3
3C chemical shifts for the heparin-like compound of the crab G. cruentata.
Unit 13C chemical shiftsa
Uronic acid 
C1 C2 C3 C4 
a(-GlcA)→-d-GlcNS-6S (I)→(A) 105.0 76.2 80.1 79.8 
b-GlcA→-d-GlcNS-6S 105.5 76.4 79.5 79.8 
a(-GlcA)→(-d-GlcNS) (I)→(A′) 105.0 76.2 80.1 79.8 
b-GlcA→-d-GlcNS 105.1 75.6 78.7 78.8 
a(-GlcA-2S)→(-d-GlcNS) (H)→(B/B′) 103.8 83.0 77.8 77.8 
a(-GlcA-2S)→(-d-GlcNS-6S)(H)→(B/B′) 103.8 83.0 – – 
b-GlcA-2S→-d-GlcNS-6S 102.8 82.3 77.3 79.1 
a(-IdoA-2S)→(-d-GlcNS-6S) (F)→(C) 101.8 78.8 72.0 79.5 
d-IdoA-2S→-d-GlcNS-6S 102.1 78.9 72.1 79.0 
a(-GlcA-2S)→(-d-GlcNAc-6S) (G)→(D) 103.8 82.8 – – 
e-GlcA-2S→-d-GlcNAc-6S 103.0 82.4 77.4 78.8/79
a(-GlcA)→(-d-GlcNAc-6S) (G′)→(D′) 105.5 76.2 79.0 78.9 
a(-GlcA)→(-d-GlcNAc) (J)→(E) 105.5 76.2 79.0 78.9 
b-GlcA→-d-GlcNAc 105.2 76.3 78.9 79.1 
alues in italic type indicate positions bearing a sulfate ester. A to F, Spin systems.
a Data presented in this paper.
b Casu et al. (1994).
c Yamada et al. (1995).
d Yates et al. (1996).
e Guerrini et al. (2005).glucuronic acid 2-O or 3-O sulfate, or when the glucosamine is
N-acetylated (Nader et al., 1999). Thus, an important difference
between mammalian heparin and the crab polymer is its lower level
of trisulfated disaccharides. In addition, the high levels of hexa-
and tetra-saccharides present indicated oligosaccharide blocks that
are resistant to the action of heparinase. Furthermore, hepariti-
nase II which acts upon glucosaminido-glucuronic acid linkages
where the N-acetyl or N-sulfate glucosamine is preferentially
Glucosamine
C5 C1 C2 C3 C4 C5 C6
80.1 102.0 61.2 73.1 81.2 70.0 69.0
80.3 100.8 61.1 73.1 80.6 72.3 69.5
80.1 101.5 61.2 73.1 82.1 74.5 63.2
79.3 99.9 60.5 72.4 80.7 73.3 62.4
– 101.8 61.0 73.0 72.0 70.0 62.0
– 101.8 61.0 73.0 72.0 74.2 69.0
79.5 100.9 – – – – –
71.8 100.5 ∼61 – – – 70.1
72.3 99.5 60.7 72.5 78.8 72.0 69.2
– 100.8 56.4 – – – 71.7
.5 79.2/79.5 99.8 56.0 72.1 80.5 72.0 68.8
79.7 100.8 56.8 – – 69.8 70.0
79.7 101.7 56.7 77.9 73.2 72.1 63.0
79.1 99.6 56.1 73.5 81.1 72.0 62.2
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esults in aPPT and anti-IIa are statistically different for the 3 compounds (P < 0.5). S
s  well as Hepn and enoxaparin.
ulfated at the C-6 position (Dietrich et al., 1999a; Nader et al.,
990), produced mainly disulfated disaccharides (UA-GlcNS,6S/
UA,2S-GlcNAc,6S/ UA,2S-GlcNS). Since the use of individual
nzymes led to the formation of oligosaccharides, a mixture of
ll three lyases was then used to ascertain the total disaccharide
omposition of the Hepn (Table 1). This result contrasts with data
btained for heparin, where about 80% all of disaccharides are the
UA,2S-GlcNS,6S, as well as for heparan sulfates where around
0–60% of all disaccharides are UA-GlcNAc/UA-GlcNS (Dietrich
t al., 1998; Zhang, Xie, Liu, Liu, & Linhardt, 2009).
.4. NMR  spectroscopy
The 1H NMR  spectrum for Hepn is shown in Fig. 2a. The signal
t 5.22 ppm from H-1 of 2-O-sulfated iduronic acid was  found in
he crab heparin-like product. The other anomeric protons showed
wo main regions from 5.28 to 5.57 ppm and 4.5 to 5.2 ppm that
orrespond to anomeric protons of the hexosamine and uronic acid
esidues, respectively (Yates et al., 1996). The signal at 2.04 ppm dueassays. (), crab Hepn; (),UFH; (), enoxaparin (low molecular weight heparin).
ant differences (P < 0.5) in PT, TT, HEPTEST and anti-Xa between Hepn and heparin,
to the acetyl groups was  prominent in the Hepn. Fig. 2b shows the
anomeric region for porcine heparin, bovine heparan sulfate and
the crab Hepn. It is clear that the same anomeric signals present in
heparin and heparan sulfate are present in Hepn. Nevertheless, as
in the enzymatic degradation results, they are present in different
relative proportions.
Two-dimensional assignment techniques of COSY, TOCSY,
NOESY and HSQC were used to trace the spin systems from
the heparin-like structure. The HSQC and COSY spectra of the
heparin-like compound are shown in Fig. 3. The chemical shifts
in Tables 2 and 3 were based on the interpretations of these spec-
tra. The distribution of the spin systems can be detected by the
presence of more than one H/C correlation signal in the anomeric
region of the HSQC spectrum (Fig. 3a). Thus, several spin systems
were traced (see Tables 2 and 3). Signals at 4.60/105.0 ppm and
at 4.49–4.52/105.5 ppm indicate glucuronic acid residues linked to
N-sulfated and N-acetylated glucosamines, respectively; signals at
4.70/103.1 and at 4.73/104.0 ppm indicate 2-O-sulfated glucuronic
acid residues linked to N-sulfated and N-acetylated glucosamines,
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espectively, and the signal at 5.2/101.8 ppm indicates 2-O-sulfated
doA linked to N-sulfated glucosamine (Guerrini, Naggi, Guglieri,
antarsiero, & Torri, 2005; Yates et al., 1996). Traceable spin sys-
ems are also shown on the homonuclear proton–proton COSY
pectrum exhibiting the spin–spin coupled protons (Fig. 3b).
The  crab heparin-like compound exhibited NMR  spectra con-
aining similar characteristics to mammalian heparan sulfate,
ncluding a high intensity signal attributed to the acetyl groups
nd high intensity signals of H-1 from glucuronic acid residues.
dditionally, the signals attributed to the anomeric proton of
-O-sulfated iduronic acid residues (5.2 ppm), common to mam-
alian heparin (Casu et al., 1994; Mulloy et al., 1994; Yates et al.,
996), were also detected, yet, these 2-O-sulfated iduronic acid
esidues are linked either to N-sulfated, 6-hydroxyl or N-acetylated,
-O-sulfated glucosamine (Fig. 2b). Furthermore, chemical shifts
t 4.7–4.73 ppm attributed to the 2-O-sulfated glucuronic acid
ere also present. According to the literature, low amounts of
-O-sulfated glucuronic acid residues are found in natural gly-
osaminoglycans, but this residue is usually not detectable in
nfractionated heparins (Guerrini et al., 2005; Yamada, Murakami,
suda, Yoshida, & Sugahara, 1995). To the best of our knowledge,
his is the ﬁrst report of a 2-O-sulfated glucuronic acid-rich heparin-
ike compound.
The NMR  signals attributed to N,3,6-trisulfated glucosamine
esidue, a typical marker of the pentasaccharide sequence of the
ctive site of heparin and heparan sulfates for antithrombin bind-
ng (Casu et al., 1996; Kusche, Torri, Casu, & Lindahl, 1990; Lindahl
t al., 2005; Sie et al., 1988), were not detected in the spectra of
he crab heparin-like compound, suggesting that such compound
s likely to exhibit reduced anticoagulant activity when compared
o heparin.
.5. In vitro anticoagulant assays
In vitro anticoagulant activity of the crab heparin-like compound
s shown in Fig. 4. The Hepn exhibited an anticoagulant activity
round 33 IU/mg using the activated partial thromboplastin time
aPTT) assay. This method shows that the compound, when com-
ared to heparin (193 IU/mg), is at least 5 times less potent in
reventing in vitro clot formation by the intrinsic pathway. The crab
ompound had no effect in the extrinsic pathway, conﬁrmed by the
rothrombin time (PT), dramatically contrasting with mammalian
eparin. Hepn has no effect on the ability of thrombin to degrade
brinogen measured by the thrombin time (TT), contrasting once
ore the effect observed with heparin. The HEPTEST test measures
he action of the compounds upon heparin cofactor II. The results
ndicated that Hepn is at least 12 times less potent than heparin in
his assay. Using biochemically deﬁned conditions on a fast kinetic
entrifugal analyzer, the effects of the heparin-like, heparin and
noxaparin on thrombin and factor Xa generation were also inves-
igated. It is evident that the heparin-like compound is much less
otent in the direct generation of thrombin and factor Xa when
ompared to heparin and enoxaparin. Consequently, these results
ndicated that Hepn from G. cruentata is a less potent anticoag-
lant agent than mammalian heparin and LMW-heparin (Fig. 4).
his lower anticoagulant activity can be related to its lower degree
f sulfation, in particular, the lack of N,3,6-trisulfated glucosamine
esidues, a typical marker of the pentasaccharide sequence active
or antithrombin (Lindahl et al., 2005).
.6. Hemorrhagic effectCrab  Hepn was also tested as a possible inhibitor of hemosta-
is. The crab compound, like heparin, also disrupted the normal
ontrol of bleeding. Nevertheless, the extent of bleeding in the ani-
als exposed to the crab compound was less pronounced than theFig. 5. Bleeding activity of the crab heparin-like compound and porcine intesti-
nal  mucosa heparin. (), Hepn; (), mammalian heparin. The results for the two
compounds  are statistically different (P < 0.5).
heparin treatment (Fig. 5). This could be related to the lower con-
tent of critical sulfation at the C-6 position of the glucosamine.
Studies conducted with disaccharides derived from heparin, hep-
aran sulfate and chondroitin sulfate showed that a sulfate at the
C-6 position of the glucosamine is crucial for the antihemostatic
activity (Dietrich, Tersariol, Da Silva, Bianchini, & Nader, 1991).
The ﬁndings that other sulfated disaccharides, with the same sul-
fate/hexosamine/uronic acid ratios bearing a sulfate at a different
position (C-2) or with a different glycosidic linkage (1–3), were
inactive as inhibitors of hemostasis indicating that a speciﬁc struc-
ture is needed for such an effect (Dietrich et al., 1991). On  the other
hand, this inhibitory activity does not seem to be related to the
anticoagulant activity of the compounds (Boucas et al., 2012) since
structures with no anticoagulant activity are potent antihemostatic
agents (Nader, Tersariol, & Dietrich, 1989).
4. Conclusion
In summary, our results indicate that the heparin-like com-
pound isolated from the crab G. cruentata present intermediate
structure between heparin and heparan sulfate. In addition, the
crab heparin-like is rich in 2-O-sulfated glucuronic acid residues,
possesses low levels of trisulfated disaccharides and lacks the
deﬁned pentasaccharide structure related to the antithrombin
binding site. To the best of our knowledge, this is the ﬁrst
study characterizing a natural 2-O-sulfated glucuronic acid-rich
heparin-like glycosaminoglycan using chemical, enzymatic and
spectroscopic analyses. Furthermore, concerning some pharmaco-
logical activities, it has been demonstrated that, the crab compound
showed negligible in vitro anticoagulant activity and lower bleeding
effect compared to mammalian heparin. Consequently, its unusual
structural features, insigniﬁcant in vitro anticoagulant activity and
lower bleeding risk, make this compound a suitable candidate
for the development structure-driven heparin based therapeutic
agents with less undesirable effects.
Acknowledgments
This work was supported by grants from FAPESP (Fundac¸ ão
de Amparo a Pesquisa do Estado de São Paulo), CNPq (Con-
selho Nacional de Desenvolvimento Cientíﬁco e Tecnológico) and
CAPES (Coordenac¸ ão de Aperfeic¸ oamento de Pessoal de Nível Supe-
rior). The authors thank Dr. Ana Paula Valente for the use of the
NMR equipment located at the Centro Nacional de Ressonância
Nuclear Magnética (UFRJ, Rio de Janeiro, Brazil). NMR  data were
also obtained at the Advanced Magnetic Resonance Imaging and
6 drate
S
t
M
R
B
B
B
B
C
C
C
C
C
C
D
D
D
D
D
D
D
D
D
D54 G.P.V.  Andrade et al. / Carbohy
pectroscopy (AMRIS) facility in the McKnight Brain Institute of
he University of Florida and supported through the National High
agnetic Field Laboratory.
eferences
ianchini, P., Nader, H. B., Takahashi, H. K., Osima, B., Straus, A. H., & Diet-
rich,  C. P. (1980). Fractionation and identiﬁcation of heparin and other acidic
mucopolysaccharide by a new discontinuous eletroforetic method. Journal of
Chromatography, 196, 455–462.
oucas, R. I., Jarrouge-Boucas, T. R., Lima, M. A., Trindade, E. S., Moraes, F. A., Cav-
alheiro, R. P., et al. (2012). Glycosaminoglycan backbone is not required for
the  modulation of hemostasis: Effect of different heparin derivatives and non-
glycosaminoglycan  analogs. Matrix Biology, 31(5), 308–316.
oucas,  R. I., Sampaio, L. O., Andrade, G. P. V., Lopes, C. C., Nascimento, F. D., Tersariol, I.
L. S., et al. (2006). Heparin and heparin derivatives and their effect on hemostasis.
In  H. Verli (Ed.), Insights into carbohydrate structure and biological function (pp.
25–50).  Kerala, India: Transworld Research Network.
rito, A. S., Arimateia, D. S., Souza, L. R., Lima, M.  A., Santos, V. O., Medeiros, V. P.,
et al. (2008). Anti-inﬂammatory properties of a heparin-like glycosaminoglycan
with  reduced anti-coagulant activity isolated from a marine shrimp. Bioorganic
and  Medicinal Chemistry, 16(21), 9588–9595.
assaro, C. M.,  & Dietrich, C. P. (1977). Distribution of sulfated mucopolysaccharides
in  invertebrates. Journal of Biological Chemistry, 252(7), 2254–2261.
asu,  B., Grazioli, G., Razi, N., Guerrini, M.,  Naggi, A., Torri, G., et al. (1994). Heparin-
like  compounds prepared by chemical modiﬁcation of capsular polysaccharide
from  E. coli K5. Carbohydrate Research, 263(2), 271–284.
asu,  B., Guerrini, M.,  Naggi, A., Torri, G., De-Ambrosi, L., Boveri, G., et al. (1996). Char-
acterization of sulfation patterns of beef and pig mucosal heparins by nuclear
magnetic  resonance spectroscopy. Arzneimittel-Forschung,  46(5), 472–477.
asu, B., Naggi, A., & Torri, G. (2010). Heparin-derived heparan sulfate mimics
to  modulate heparan sulfate–protein interaction in inﬂammation and cancer.
Matrix  Biology, 29(6), 442–452.
avalcante,  M.  C., Allodi, S., Valente, A. P., Straus, A. H., Takahashi, H. K., Mourao, P. A.,
et al. (2000). Occurrence of heparin in the invertebrate styela plicata (Tunicata)
is  restricted to cell layers facing the outside environment. An ancient role in
defense?  Journal of Biological Chemistry, 275(46), 36186–36189.
havante, S. F., Santos, E. A., Oliveira, F. W.,  Guerrini, M.,  Torri, G., Casu, B., et al.
(2000).  A novel heparan sulphate with high degree of N-sulphation and high
heparin  cofactor-II activity from the brine shrimp Artemia franciscana. Interna-
tional  Journal of Biological Macromolecules, 27(1), 49–57.
esai,  U. R., Wang, H. M.,  & Linhardt, R. J. (1993). Speciﬁcity studies on the heparin
lyases  from Flavobacterium heparinum. Biochemistry, 32(32), 8140–8145.
ietrich, C. P., de Paiva, J. F., Moraes, C. T., Takahashi, H. K., Porcionatto, M.  A., & Nader,
H. B. (1985). Isolation and characterization of a heparin with high anticoagulant
activity  from Anomalocardia brasiliana. Biochimica et Biophysica Acta, 843(1-2),
1–7.
ietrich,  C. P., & Nader, H. B. (1974). Fractionation and properties of four hepar-
itin  sulfates from beef lung tissue. Isolation and partial characterization of a
hemogeneous species of heparitin sulfate. Biochimica et Biophysica Acta, 343(1),
34–44.
ietrich, C. P., Paiva, J. F., Castro, R. A., Chavante, S. F., Jeske, W.,  Fareed, J., et al. (1999).
Structural  features and anticoagulant activities of a novel natural low molecular
weight  heparin from the shrimp Penaeus brasiliensis. Biochimica et Biophysica
Acta,  1428(2-3), 273–283.
ietrich,  C. P., Shinjo, S. K., Moraes, F. A., Castro, R. A., Mendes, A., Gouvea, T. C., et al.
(1999). Structural features and bleeding activity of commercial low molecular
weight  heparins: Neutralization by ATP and protamine. Seminars in Thrombosis
and  Hemostasis, 25(Suppl 3), 43–50.
ietrich, C. P., Tersariol, I. L., Da Silva, R. G., Bianchini, P., & Nader, H. B. (1991).
Dependence  of the C-6 sulfate of the glucosamine moiety and 1–4 glycosidic
linkage  of heparin disaccharides for production of hemorrhage: Reversal of the
antihemostatic activity of heparin and their fragments by adenosine triphos-
phate  and myosin. Seminars in Thrombosis and Hemostasis, 17(Suppl 1), 65–73.
ietrich, C. P., Tersariol, I. L., Toma, L., Moraes, C. T., Porcionatto, M.  A., Oliveira, F. W.,
et al. (1998). Structure of heparan sulfate: Identiﬁcation of variable and constant
oligosaccharide  domains in eight heparan sulfates of different origins. Cell and
Molecular Biology (Noisy-le-grand), 44(3), 417–429.
ische, Z. A. (1947). A new speciﬁc color reaction of hexuronic acid. Journal of Bio-
logical Chemistry, 167, 189–193.
odgson,  K. S., & Price, R. G. (1962). A note on the determination of the
ester  sulphate content of sulphated polysaccharides. Biochemical Journal, 84,
106–110.
reyfuss,  J. L., Regatieri, C. V., Lima, M.  A., Paredes-Gamero, E. J., Brito, A. S., Chavante,
S.  F., et al. (2010). A heparin mimetic isolated from a marine shrimp suppresses
neovascularization. Journal of Thrombosis and Haemostasis, 8(8), 1828–1837. Polymers 94 (2013) 647– 654
Guerrini, M.,  Naggi, A., Guglieri, S., Santarsiero, R., & Torri, G. (2005). Complex gly-
cosaminoglycans: Proﬁling substitution patterns by two-dimensional nuclear
magnetic  resonance spectroscopy. Analytical Biochemistry, 337(1), 35–47.
Kaiser, B., Fareed, J., Hoppensteadt, D., Birdsong, B., Walenga, J. M.,  & Markwardt,
F.  (1992). Inﬂuence of recombinant hirudin and unfractionated heparin on
thrombin and factor Xa generation in extrinsic and intrinsic activated systems.
Thrombosis  Research, 65(2), 157–164.
Kusche, M.,  Torri, G., Casu, B., & Lindahl, U. (1990). Biosynthesis of heparin. Availabil-
ity  of glucosaminyl 3-O-sulfation sites. Journal of Biological Chemistry, 265(13),
7292–7300.
Lindahl,  U., Li, J. P., Kusche-Gullberg, M.,  Salmivirta, M., Alaranta, S., Veromaa, T.,
et al. (2005). Generation of “neoheparin” from E. coli K5 capsular polysaccharide.
Journal  of Medicinal Chemistry, 48(2), 349–352.
Luppi, E., Cesaretti, M.,  & Volpi, N. (2005). Puriﬁcation and characterization of heparin
from the Italian clam Callista chione. Biomacromolecules, 6(3), 1672–1678.
Medeiros,  G. F., Mendes, A., Castro, R. A., Bau, E. C., Nader, H. B., & Dietrich, C. P.
(2000).  Distribution of sulfated glycosaminoglycans in the animal kingdom:
Widespread  occurrence of heparin-like compounds in invertebrates. Biochimica
et Biophysica Acta, 1475(3), 287–294.
Mulloy, B., Forster, M.  J., Jones, C., Drake, A. F., Johnson, E. A., & Davies, D. B. (1994).
The  effect of variation of substitution on the solution conformation of heparin: A
spectroscopic and molecular modelling study. Carbohydrate Research, 255, 1–26.
Nader, H. B., Kobayashi, E. Y., Chavante, S. F., Tersariol, I. L., Castro, R. A., Shinjo, S. K.,
et al. (1999). New insights on the speciﬁcity of heparin and heparan sulfate lyases
from  Flavobacterium heparinum revealed by the use of synthetic derivatives of K5
polysaccharide from E. coli and 2-O-desulfated heparin. Glycoconjugate Journal,
16(6),  265–270.
Nader, H. B., Lopes, C. C., Rocha, H. A., Santos, E. A., & Dietrich, C. P. (2004). Heparins
and  heparinoids: Occurrence, structure and mechanism of antithrombotic and
hemorrhagic activities. Current Pharmaceutical Design, 10(9), 951–966.
Nader, H. B., Porcionatto, M.  A., Tersariol, I. L., Pinhal, M. A., Oliveira, F. W.,  Moraes,
C.  T., et al. (1990). Puriﬁcation and substrate speciﬁcity of heparitinase I and
heparitinase  II from Flavobacterium heparinum. Analyses of the heparin and hep-
aran sulfate degradation products by 13C NMR  spectroscopy. Journal of Biological
Chemistry,  265(28), 16807–16813.
Nader,  H. B., Tersariol, I. L., & Dietrich, C. P. (1989). Antihemostatic activity of heparin
disaccharides and oligosaccharides obtained by chemical and enzymatic frag-
mentation: Reversal of the hemorrhagic activity by ATP and myosin. Thrombosis
Research,  54(3), 207–214.
Paredes-Gamero, E. J., Medeiros, V. P., Farias, E. H., Justo, G. Z., Trindade, E. S.,
Andrade-Lopes, A. L., et al. (2010). Heparin induces rat aorta relaxation via
integrin-dependent activation of muscarinic M3 receptors. Hypertension, 56(4),
713–721.
Pejler,  G., Danielsson, A., Bjork, I., Lindahl, U., Nader, H. B., & Dietrich, C. P. (1987).
Structure  and antithrombin-binding properties of heparin isolated from the
clams  Anomalocardia brasiliana and Tivela mactroides. Journal of Biological Chem-
istry, 262(24), 11413–11421.
Rondle,  C. J., & Morgan, W.  T. (1955). The determination of glucosamine and galac-
tosamine. Biochemical Journal, 61(4), 586–589.
Sampaio, L. O., Tersariol, I. L. S., Lopes, C. C., Bouc¸ as, R. I., Nascimento, F. D., Rocha, H.
A., et al. (2006). Heparin and heparan sulfates. Structure distribution and protein
interactions.  In H. Verli (Ed.), Insights into carbohydrate structure and biological
function  (pp. 1–24). Kerala, India: Transworld Research Network.
Santos,  J. C., Mesquita, J. M.,  Belmiro, C. L., da Silveira, C. B., Viskov, C., Mourier, P. A.,
et al. (2007). Isolation and characterization of a heparin with low antithrombin
activity  from the body of Styela plicata (Chordata-Tunicata). Distinct effects on
venous and arterial models of thrombosis. Thrombosis Research, 121(2), 213–223.
Sie, P., Petitou, M.,  Lormeau, J. C., Dupouy, D., Boneu, B., & Choay, J. (1988). Studies on
the structural requirements of heparin for the catalysis of thrombin inhibition
by  heparin cofactor II. Biochimica et Biophysica Acta, 966(2), 188–195.
Silva,  M. E., & Dietrich, C. P. (1974). Isolation and partial characterization of three
induced  enzymes from Flavobacterium heparinum involved in the degradation
of  heparin and heparitin sulfates. Biochemical and Biophysical Research Commu-
nications,  56(4), 965–972.
Toledo,  O. M.,  & Dietrich, C. P. (1977). Tissue speciﬁc distribution of sulfated
mucopolysaccharides in mammals. Biochimica et Biophysica Acta, 498(1),
114–122.
Yamada,  S., Murakami, T., Tsuda, H., Yoshida, K., & Sugahara, K. (1995). Isolation of
the porcine heparin tetrasaccharides with glucuronate 2-O-sulfate. Heparinase
cleaves  glucuronate 2-O-sulfate-containing disaccharides in highly sulfated
blocks  in heparin. Journal of Biological Chemistry, 270(15), 8696–8705.
Yates,  E. A., Santini, F., Guerrini, M.,  Naggi, A., Torri, G., & Casu, B. (1996). 1H and
13C  NMR spectral assignments of the major sequences of twelve systematically
modiﬁed  heparin derivatives. Carbohydrate Research, 294, 15–27.
Zhang,  Z., Xie, J., Liu, H., Liu, J., & Linhardt, R. J. (2009). Quantiﬁcation of
heparan  sulfate disaccharides using ion-pairing reversed-phase microﬂow high-
performance liquid chromatography with electrospray ionization trap mass
spectrometry.  Analytical Chemistry, 81(11), 4349–4355.
